Font Size: a A A
Keyword [Castration resistant prostate cancer]
Result: 81 - 100 | Page: 5 of 7
81. Promotive Effect Of PLC? On Androgen Receptor Antagonist Resistance Via The BMP-6/SMAD Axis In Castration-resistant Prostate Cancer
82. Loss Of Epithelial Androgen Receptor Promotes Castration-resistant Prostate Cancer Metastasis Via TGF-?1 Induced Epithelial–mesenchymal Transition (EMT)
83. The Expression And Its Clinical Significance Of FOXA1 In Castration-resistant Prostate Cancer
84. Research On The Mechanism Of Nrf2/HO-1 On Ferroptosis In Castration Resistant Prostate Cancer
85. The Role And Mechanism Of SCIN In The Development Of Castration?resistant Prostate Cancer
86. Bioinformatics Analysis Of Differentially Expressed Genes And Key Pathways In Castration Resistant Prostate Cancer
87. Clinical Study Of Chinese Medicine CFF-1 Combined With Chemotherapy On Treating Metastatic Castration-Resistant Prostate Cancer
88. Correlation Between Prostate-specific Antigen Dynamics And Progression Time Of Castration-Resistant Prostate Cancer After Androgen Deprivation
89. Functional Evaluation Of PSMA-CAR-T Cells Coexpressing IL-7 And CCL19 In The Treatment Of Prostate Cancer
90. Clinical Observation Of Lenalidomide Combined With Abiraterone In The Treatment Of Castration-resistant Prostate Cancer With Bone Metastases
91. The Therapeutic Effect Of TURP Plus Novel Endocrine Therapy On Patients In Their Terminal Stage Of CRPC With BOO
92. Genetic Testing Guides The Treatment Of Castration-resistant Prostate Cancer:A Case Report And Literature Review
93. Analysis Of Related Factors Of Castration-resistant Prostate Cancer
94. Study Following A Steroid Switch From Prednisone To Dexamethasone In Castration-resistant Prostate Cancer Patients Progressing On Abiraterone
95. Analysis Of Risk Factors For Progression To Castration-resistant Prostate Cancer In Castration-sensitive Prostate Cancer Patients
96. The Effect Of Geranium On The Proliferation And Migration Of Castration-resistant Prostate Cancer Cells
97. In vitro and quantitative phosphoproteomic modeling of castration resistant prostate cancer
98. Nrf1 and Nrf2 Mediated Regulation of Androgen Receptor Signaling in Castration Resistant Prostate Cancer
99. Inhibiting LSD1 restores vitamin D responsiveness in castration resistant prostate cancer
100. Simultaneous targeting of endoplasmic reticulum stress and AKT pathways as a novel chemosensitization approach against castration resistant prostate cancer
  <<First  <Prev  Next>  Last>>  Jump to